Keywords: elan, biogen, idec, seek, approval, antegren, europe

Elan and Biogen Idec to seek approval of Antegren in Europe for Crohn's disease

Article | 24 May 2004

Print This

Ireland's Elan Corp and USA-based biotechnology firm Biogen Idec say that they intend to submit a Marketing Authorization Application to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in